Whole genome sequencing offered to breast cancer patients is likely to identify unique genetic features that could either ...

Non-communicable diseases (NCDs) now account for seven of the world's ten leading causes of death and kill 18 million people ...

A dexamethasone-sparing regimen involving lenalidomide (Revlimid) and the anti-CD38 drug daratumumab (Darzalex) was safe and ...

A simple test could transform the lives of thousands of women with breast cancer by leading to more effective and ...

It was a quiet summer, and I was determined to switch off—no clinics, no case logs, just rest. One afternoon, while unpacking ...

Whole genome sequencing offered to breast cancer patients is likely to identify unique genetic features that could either ...

At a median follow-up of 39.4 months, results from the second interim analysis showed a sustained and significant OS benefit with BVd compared to DVd.

Last week, Lancet Oncology released a special report, "Future Cancer Research Priorities in the USA: A Lancet Oncology Commission." As co-author of this report, I joined fellow cancer research experts ...

Given the potential for volatility in future cancer research and global health funding from the USA due to federal funding cuts, there might be increased strategic value in other countries ...

Cancer deaths are projected to rise, reaching over 18 million by 2050, marking a nearly 75% increase from 2024, according to a new analysis published in The Lancet by the Global Burden of Disease ...